Affymetrix (Santa Clara, California) And Sysmex Corporation Join Forces To Develop And Market In-Vitro Diagnostic Tests
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that it has signed two agreements with Sysmex Corporation of Kobe, Japan, to distribute, develop and market in-vitro diagnostic tests. A Clinical Development and Marketing Agreement grants Sysmex exclusive rights to distribute Affymetrix’ diagnostic microarray products and instrumentation in Japan with the opportunity to expand into certain Asia Pacific countries. In addition, a Powered by Affymetrix™ agreement gives Sysmex non-exclusive access to Affymetrix microarray technology to develop and market in-vitro diagnostic tests on a worldwide basis.